Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report

Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report

Abstract Background Teriflunomide, the active metabolite of leflunomide, is a disease-modifying therapy drug used for the treatment of multiple sclerosis (MS), yet the complications associated with this drug remain not fully understood. Here we present the rare case of a 28-year-old female MS patien...

Full description

Bibliographic Details
Main Authors: Ke Xu, Mengjie Zhang, Shilin Yang, Gang Yu, Peng Zheng, Xinyue Qin, Jinzhou Feng
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Subacute cutaneous lupus erythematosus
Teriflunomide
Leflunomide
Autoimmune diathesis
Case report
Online Access:https://doi.org/10.1186/s12883-023-03146-1

Internet

https://doi.org/10.1186/s12883-023-03146-1

Similar Items